MCL-1 Inhibition Causes Cell Death in hiPSC-CMs that is Blocked by a Necrosis Inhibitor
(A and B) hiPSC-CMs were treated with increasing doses of S63845 (A) or AMG-176, and AZD5991 (B) for 48 h before caspase activity was measured by CaspaseGlo 3/7 assay (Promega). Quantification shows results from at least three independent experiments performed in duplicate and were normalized to DMSO control. Graphs represent mean ± SEM.
(C) CellTiter-Blue assay (Promega) was used to assess cell viability in hiPSC-CMs. p values were calculated by one-way ANOVA. Data was quantified from three independent experiments performed in triplicate. Boxplots show median with Tukey whiskers.
See also Figure S5.